2024-519301-36-00CompletedPhase 1
A study to test different doses of BI 765049 in people with advanced cancer of the colon, rectum, stomach, or pancreas
Source: EU CTIS (euclinicaltrials.eu) · Last updated 18 Jul 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 14 Mar 2025
- Start date
- 11 Jul 2025
- Lead sponsor
- Boehringer Ingelheim International GmbH
- Diseases
- Colorectal cancer
- EU CT number
- 2024-519301-36-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 40
- 3 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (3)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Technische Universitaet Dresden | Dresden | Germany | Completed |
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | Completed |
| Hospital Clinico Universitario de Valencia | Valencia | Spain | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.